Atlanta Tuberculosis Prevention Coalition. (2001). Georgia TB reference guide. Atlanta, GA: Emory University School of Medicine.
2.
Centers for Disease Control and Prevention. (1994). Guidelines for preventing the transmission of m. tuberculosis in health care facilities. Morbidity and Mortality Weekly Report, 43(RR13), 1–132.
3.
Centers for Disease Control and Prevention. (2000). Targeted tuberculin testing and treatment of latent tuberculosis infection. Morbidity and Mortality Weekly Report, 49(RR-6), 1–51.
4.
Centers for Disease Control and Prevention. (2001). Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society/CDC recommendations—United States, 2001. Morbidity and Mortality-Weekly Report, 50(34), 733–735.
5.
ChesnuttM.S., & PrendergastT.J. (2000). Pulmonary tuberculosis. Current medical diagnosis and treatment 2000 (39th ed., pp. 301–307). Columbus, OH: Lange Medical Books/McGraw-Hill.
6.
MenziesR. (2002). Interpreting repeated tuberculin skin tests. Guidelines for the diagnosis of latent tuberculosis infection for the 21st century (pp. 39–47). Newark: NJ Medical School National Tuberculosis Center.
7.
ReichmanL.B. (2002). Guidelines for the diagnosis of latent tuberculosis infection for the 21st century [Introduction] (pp. 1–7). Newark, NJ: NJ Medical School National Tuberculosis Center.
8.
SepkowitzK.A. (2001). Tuberculosis in the 21st century. Centers for Disease Control—Emerging Infectious Diseases, 7(2), 1–9.